Polaris Venture Management Co. V as of Sept. 30, 2018
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 12 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cardlytics (CDLX) | 32.0 | $64M | 2.6M | 25.04 | |
| Fate Therapeutics (FATE) | 20.2 | $40M | 2.5M | 16.29 | |
| Neuronetics (STIM) | 13.2 | $26M | 825k | 32.06 | |
| Selecta Biosciences | 12.5 | $25M | 1.6M | 15.55 | |
| Kala Pharmaceuticals | 9.2 | $18M | 1.9M | 9.87 | |
| T2 Biosystems | 6.9 | $14M | 1.8M | 7.45 | |
| Trevena | 2.2 | $4.4M | 2.1M | 2.12 | |
| Arsanis | 1.5 | $3.0M | 1.9M | 1.62 | |
| Genocea Biosciences | 0.8 | $1.5M | 2.0M | 0.78 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.7 | $1.5M | 1.8M | 0.81 | |
| Pulmatrix | 0.7 | $1.3M | 3.6M | 0.37 | |
| Dare Bioscience | 0.2 | $317k | 326k | 0.97 |
